Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients
Identifieur interne : 001E10 ( Pmc/Curation ); précédent : 001E09; suivant : 001E11Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients
Auteurs : Geurt Van De Glind [Pays-Bas] ; Wim Van Den Brink [Pays-Bas] ; Maarten W. J. Koeter [Pays-Bas] ; Pieter-Jan Carpentier [Pays-Bas] ; Katelijne Van Emmerik-Van Oortmerssen [Pays-Bas] ; Sharlene Kaye [Australie] ; Arvid Skutle [Norvège] ; Eli-Torild H. Bu [Norvège] ; Johan Franck [Suède] ; Maija Konstenius [Suède] ; Franz Moggi [Suisse] ; Geert Dom [Belgique] ; Sofie Verspreet [Belgique] ; Zsolt Demetrovics [Hongrie] ; Máté Kapitány-Fövény [Hongrie] ; Melina Fatséas [France] ; Marc Auriacombe [France] ; Arild Schillinger [Norvège] ; Andrea Seitz [Suisse] ; Brian Johnson [États-Unis] ; Stephen V. Faraone [États-Unis] ; J. Antoni Ramos-Quiroga [Espagne] ; Miguel Casas [Espagne] ; Steve Allsop [Australie] ; Susan Carruthers [Australie] ; Csaba Barta [Hongrie] ; Robert A. Schoevers [Pays-Bas] ; Frances R. Levin [États-Unis]Source :
- Drug and alcohol dependence [ 0376-8716 ] ; 2013.
Abstract
To detect attention deficit hyperactivity disorder (ADHD) in treatment seeking substance use disorders (SUD) patients, a valid screening instrument is needed.
To test the performance of the Adult ADHD Self-Report Scale V1.1(ASRS) for adult ADHD in an international sample of treatment seeking SUD patients for DSM-IV-TR; for the proposed DSM-5 criteria; in different subpopulations, at intake and 1–2 weeks after intake; using different scoring algorithms; and different externalizing disorders as external criterion (including adult ADHD, bipolar disorder, antisocial and borderline personality disorder).
In 1138 treatment seeking SUD subjects, ASRS performance was determined using diagnoses based on Conner’s Adult ADHD Diagnostic Interview for DSM-IV (CAADID) as gold standard.
The prevalence of adult ADHD was 13.0% (95% CI: 11.0–15.0%). The overall positive predictive value (PPV) of the ASRS was 0.26 (95% CI: 0.22–0.30), the negative predictive value (NPV) was 0.97 (95% CI: 0.96–0.98). The sensitivity (0.84, 95% CI: 0.76–0.88) and specificity (0.66, 95% CI: 0.63–0.69) measured at admission were similar to the sensitivity (0.88,95% CI: 0.83–0.93) and specificity (0.67,95% CI: 0.64–0.70) measured 2 weeks after admission. Sensitivity was similar, but specificity was significantly better in patients with alcohol compared to (illicit) drugs as the primary substance of abuse (0.76 vs. 0.56). ASRS was not a good screener for externalizing disorders other than ADHD.
The ASRS is a sensitive screener for identifying possible ADHD cases with very few missed cases among those screening negative in this population.
Url:
DOI: 10.1016/j.drugalcdep.2013.04.010
PubMed: 23660242
PubMed Central: 4083506
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001F56
Links to Exploration step
PMC:4083506Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients</title><author><name sortKey="Van De Glind, Geurt" sort="Van De Glind, Geurt" uniqKey="Van De Glind G" first="Geurt" last="Van De Glind">Geurt Van De Glind</name><affiliation wicri:level="1"><nlm:aff id="A1">Trimbos-instituut and ICASA Foundation, Utrecht, The Netherlands</nlm:aff><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Trimbos-instituut and ICASA Foundation, Utrecht</wicri:regionArea></affiliation><affiliation wicri:level="1"><nlm:aff id="A2">Amsterdam Institute for Addiction Research, Amsterdam, The Netherlands</nlm:aff><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Amsterdam Institute for Addiction Research, Amsterdam</wicri:regionArea></affiliation></author><author><name sortKey="Van Den Brink, Wim" sort="Van Den Brink, Wim" uniqKey="Van Den Brink W" first="Wim" last="Van Den Brink">Wim Van Den Brink</name><affiliation wicri:level="1"><nlm:aff id="A2">Amsterdam Institute for Addiction Research, Amsterdam, The Netherlands</nlm:aff><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Amsterdam Institute for Addiction Research, Amsterdam</wicri:regionArea></affiliation></author><author><name sortKey="Koeter, Maarten W J" sort="Koeter, Maarten W J" uniqKey="Koeter M" first="Maarten W. J." last="Koeter">Maarten W. J. Koeter</name><affiliation wicri:level="1"><nlm:aff id="A2">Amsterdam Institute for Addiction Research, Amsterdam, The Netherlands</nlm:aff><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Amsterdam Institute for Addiction Research, Amsterdam</wicri:regionArea></affiliation></author><author><name sortKey="Carpentier, Pieter Jan" sort="Carpentier, Pieter Jan" uniqKey="Carpentier P" first="Pieter-Jan" last="Carpentier">Pieter-Jan Carpentier</name><affiliation wicri:level="1"><nlm:aff id="A3">Reinier van Arkel groep, ‘s-Hertogenbosch, The Netherlands</nlm:aff><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Reinier van Arkel groep, ‘s-Hertogenbosch</wicri:regionArea></affiliation></author><author><name sortKey="Van Emmerik Van Oortmerssen, Katelijne" sort="Van Emmerik Van Oortmerssen, Katelijne" uniqKey="Van Emmerik Van Oortmerssen K" first="Katelijne" last="Van Emmerik-Van Oortmerssen">Katelijne Van Emmerik-Van Oortmerssen</name><affiliation wicri:level="1"><nlm:aff id="A2">Amsterdam Institute for Addiction Research, Amsterdam, The Netherlands</nlm:aff><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Amsterdam Institute for Addiction Research, Amsterdam</wicri:regionArea></affiliation><affiliation wicri:level="1"><nlm:aff id="A4">Arkin, Amsterdam, The Netherlands</nlm:aff><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Arkin, Amsterdam</wicri:regionArea></affiliation></author><author><name sortKey="Kaye, Sharlene" sort="Kaye, Sharlene" uniqKey="Kaye S" first="Sharlene" last="Kaye">Sharlene Kaye</name><affiliation wicri:level="1"><nlm:aff id="A5">National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia</nlm:aff><country xml:lang="fr">Australie</country><wicri:regionArea>National Drug and Alcohol Research Centre, University of New South Wales, Sydney</wicri:regionArea></affiliation></author><author><name sortKey="Skutle, Arvid" sort="Skutle, Arvid" uniqKey="Skutle A" first="Arvid" last="Skutle">Arvid Skutle</name><affiliation wicri:level="1"><nlm:aff id="A6">Bergen Clinics Foundation, Bergen, Norway</nlm:aff><country xml:lang="fr">Norvège</country><wicri:regionArea>Bergen Clinics Foundation, Bergen</wicri:regionArea></affiliation></author><author><name sortKey="Bu, Eli Torild H" sort="Bu, Eli Torild H" uniqKey="Bu E" first="Eli-Torild H." last="Bu">Eli-Torild H. Bu</name><affiliation wicri:level="1"><nlm:aff id="A6">Bergen Clinics Foundation, Bergen, Norway</nlm:aff><country xml:lang="fr">Norvège</country><wicri:regionArea>Bergen Clinics Foundation, Bergen</wicri:regionArea></affiliation></author><author><name sortKey="Franck, Johan" sort="Franck, Johan" uniqKey="Franck J" first="Johan" last="Franck">Johan Franck</name><affiliation wicri:level="1"><nlm:aff id="A7">Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden</nlm:aff><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Clinical Neuroscience, Karolinska Institutet, Stockholm</wicri:regionArea></affiliation></author><author><name sortKey="Konstenius, Maija" sort="Konstenius, Maija" uniqKey="Konstenius M" first="Maija" last="Konstenius">Maija Konstenius</name><affiliation wicri:level="1"><nlm:aff id="A7">Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden</nlm:aff><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Clinical Neuroscience, Karolinska Institutet, Stockholm</wicri:regionArea></affiliation></author><author><name sortKey="Moggi, Franz" sort="Moggi, Franz" uniqKey="Moggi F" first="Franz" last="Moggi">Franz Moggi</name><affiliation wicri:level="1"><nlm:aff id="A8">University Hospital of Psychiatry Berne, Department of Psychology, University of Fribourg, Switzerland</nlm:aff><country xml:lang="fr">Suisse</country><wicri:regionArea>University Hospital of Psychiatry Berne, Department of Psychology, University of Fribourg</wicri:regionArea></affiliation></author><author><name sortKey="Dom, Geert" sort="Dom, Geert" uniqKey="Dom G" first="Geert" last="Dom">Geert Dom</name><affiliation wicri:level="1"><nlm:aff id="A9">Collaborative Antwerp Psychiatry Research Institute (CAPRI, UA), Boechout, Belgium</nlm:aff><country xml:lang="fr">Belgique</country><wicri:regionArea>Collaborative Antwerp Psychiatry Research Institute (CAPRI, UA), Boechout</wicri:regionArea></affiliation></author><author><name sortKey="Verspreet, Sofie" sort="Verspreet, Sofie" uniqKey="Verspreet S" first="Sofie" last="Verspreet">Sofie Verspreet</name><affiliation wicri:level="1"><nlm:aff id="A9">Collaborative Antwerp Psychiatry Research Institute (CAPRI, UA), Boechout, Belgium</nlm:aff><country xml:lang="fr">Belgique</country><wicri:regionArea>Collaborative Antwerp Psychiatry Research Institute (CAPRI, UA), Boechout</wicri:regionArea></affiliation></author><author><name sortKey="Demetrovics, Zsolt" sort="Demetrovics, Zsolt" uniqKey="Demetrovics Z" first="Zsolt" last="Demetrovics">Zsolt Demetrovics</name><affiliation wicri:level="1"><nlm:aff id="A10">Institute of Psychology, Eötvös Loránd University, Budapest, Hungary</nlm:aff><country xml:lang="fr">Hongrie</country><wicri:regionArea>Institute of Psychology, Eötvös Loránd University, Budapest</wicri:regionArea></affiliation></author><author><name sortKey="Kapitany Foveny, Mate" sort="Kapitany Foveny, Mate" uniqKey="Kapitany Foveny M" first="Máté" last="Kapitány-Fövény">Máté Kapitány-Fövény</name><affiliation wicri:level="1"><nlm:aff id="A10">Institute of Psychology, Eötvös Loránd University, Budapest, Hungary</nlm:aff><country xml:lang="fr">Hongrie</country><wicri:regionArea>Institute of Psychology, Eötvös Loránd University, Budapest</wicri:regionArea></affiliation><affiliation wicri:level="1"><nlm:aff id="A21">Nyírő Gyula Hospital Drug Outpatient and Prevention Center, Budapest, Hungary</nlm:aff><country xml:lang="fr">Hongrie</country><wicri:regionArea>Nyírő Gyula Hospital Drug Outpatient and Prevention Center, Budapest</wicri:regionArea></affiliation></author><author><name sortKey="Fatseas, Melina" sort="Fatseas, Melina" uniqKey="Fatseas M" first="Melina" last="Fatséas">Melina Fatséas</name><affiliation wicri:level="1"><nlm:aff id="A11">Laboratoire de psychiatrie Département d’addictologie, Université de Bordeaux, France</nlm:aff><country xml:lang="fr">France</country><wicri:regionArea>Laboratoire de psychiatrie Département d’addictologie, Université de Bordeaux</wicri:regionArea></affiliation></author><author><name sortKey="Auriacombe, Marc" sort="Auriacombe, Marc" uniqKey="Auriacombe M" first="Marc" last="Auriacombe">Marc Auriacombe</name><affiliation wicri:level="1"><nlm:aff id="A11">Laboratoire de psychiatrie Département d’addictologie, Université de Bordeaux, France</nlm:aff><country xml:lang="fr">France</country><wicri:regionArea>Laboratoire de psychiatrie Département d’addictologie, Université de Bordeaux</wicri:regionArea></affiliation></author><author><name sortKey="Schillinger, Arild" sort="Schillinger, Arild" uniqKey="Schillinger A" first="Arild" last="Schillinger">Arild Schillinger</name><affiliation wicri:level="1"><nlm:aff id="A12">Østfoldklinikken, Fredrikstad, Norway</nlm:aff><country xml:lang="fr">Norvège</country><wicri:regionArea>Østfoldklinikken, Fredrikstad</wicri:regionArea></affiliation></author><author><name sortKey="Seitz, Andrea" sort="Seitz, Andrea" uniqKey="Seitz A" first="Andrea" last="Seitz">Andrea Seitz</name><affiliation wicri:level="1"><nlm:aff id="A13">University Hospital of Psychiatry Berne, Switzerland</nlm:aff><country xml:lang="fr">Suisse</country><wicri:regionArea>University Hospital of Psychiatry Berne</wicri:regionArea></affiliation></author><author><name sortKey="Johnson, Brian" sort="Johnson, Brian" uniqKey="Johnson B" first="Brian" last="Johnson">Brian Johnson</name><affiliation wicri:level="1"><nlm:aff id="A14">Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY</wicri:regionArea></affiliation><affiliation wicri:level="1"><nlm:aff id="A15">Department of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY</wicri:regionArea></affiliation></author><author><name sortKey="Faraone, Stephen V" sort="Faraone, Stephen V" uniqKey="Faraone S" first="Stephen V." last="Faraone">Stephen V. Faraone</name><affiliation wicri:level="1"><nlm:aff id="A14">Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY</wicri:regionArea></affiliation><affiliation wicri:level="1"><nlm:aff id="A15">Department of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY</wicri:regionArea></affiliation></author><author><name sortKey="Ramos Quiroga, J Antoni" sort="Ramos Quiroga, J Antoni" uniqKey="Ramos Quiroga J" first="J. Antoni" last="Ramos-Quiroga">J. Antoni Ramos-Quiroga</name><affiliation wicri:level="1"><nlm:aff id="A16">Servei de Psiquiatria, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Spain</nlm:aff><country xml:lang="fr">Espagne</country><wicri:regionArea>Servei de Psiquiatria, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona</wicri:regionArea></affiliation></author><author><name sortKey="Casas, Miguel" sort="Casas, Miguel" uniqKey="Casas M" first="Miguel" last="Casas">Miguel Casas</name><affiliation wicri:level="1"><nlm:aff id="A16">Servei de Psiquiatria, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Spain</nlm:aff><country xml:lang="fr">Espagne</country><wicri:regionArea>Servei de Psiquiatria, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona</wicri:regionArea></affiliation></author><author><name sortKey="Allsop, Steve" sort="Allsop, Steve" uniqKey="Allsop S" first="Steve" last="Allsop">Steve Allsop</name><affiliation wicri:level="1"><nlm:aff id="A17">National Drug Research Institute/Curtin University of Technology, Perth, Australia</nlm:aff><country xml:lang="fr">Australie</country><wicri:regionArea>National Drug Research Institute/Curtin University of Technology, Perth</wicri:regionArea></affiliation></author><author><name sortKey="Carruthers, Susan" sort="Carruthers, Susan" uniqKey="Carruthers S" first="Susan" last="Carruthers">Susan Carruthers</name><affiliation wicri:level="1"><nlm:aff id="A17">National Drug Research Institute/Curtin University of Technology, Perth, Australia</nlm:aff><country xml:lang="fr">Australie</country><wicri:regionArea>National Drug Research Institute/Curtin University of Technology, Perth</wicri:regionArea></affiliation></author><author><name sortKey="Barta, Csaba" sort="Barta, Csaba" uniqKey="Barta C" first="Csaba" last="Barta">Csaba Barta</name><affiliation wicri:level="1"><nlm:aff id="A18">Institute of Medical Chemistry, Molecular Biology, Pathobiochemistry, Semmelweis University, Budapest, Hungary</nlm:aff><country xml:lang="fr">Hongrie</country><wicri:regionArea>Institute of Medical Chemistry, Molecular Biology, Pathobiochemistry, Semmelweis University, Budapest</wicri:regionArea></affiliation></author><author><name sortKey="Schoevers, Robert A" sort="Schoevers, Robert A" uniqKey="Schoevers R" first="Robert A." last="Schoevers">Robert A. Schoevers</name><affiliation wicri:level="1"><nlm:aff id="A19">Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands</nlm:aff><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen</wicri:regionArea></affiliation></author><author><name sortKey="Levin, Frances R" sort="Levin, Frances R" uniqKey="Levin F" first="Frances R." last="Levin">Frances R. Levin</name><affiliation wicri:level="1"><nlm:aff id="A20">Columbia University/The New York State Psychiatric Institute, New York, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Columbia University/The New York State Psychiatric Institute, New York</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">23660242</idno><idno type="pmc">4083506</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083506</idno><idno type="RBID">PMC:4083506</idno><idno type="doi">10.1016/j.drugalcdep.2013.04.010</idno><date when="2013">2013</date><idno type="wicri:Area/Pmc/Corpus">001F56</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001F56</idno><idno type="wicri:Area/Pmc/Curation">001E10</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">001E10</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients</title><author><name sortKey="Van De Glind, Geurt" sort="Van De Glind, Geurt" uniqKey="Van De Glind G" first="Geurt" last="Van De Glind">Geurt Van De Glind</name><affiliation wicri:level="1"><nlm:aff id="A1">Trimbos-instituut and ICASA Foundation, Utrecht, The Netherlands</nlm:aff><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Trimbos-instituut and ICASA Foundation, Utrecht</wicri:regionArea></affiliation><affiliation wicri:level="1"><nlm:aff id="A2">Amsterdam Institute for Addiction Research, Amsterdam, The Netherlands</nlm:aff><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Amsterdam Institute for Addiction Research, Amsterdam</wicri:regionArea></affiliation></author><author><name sortKey="Van Den Brink, Wim" sort="Van Den Brink, Wim" uniqKey="Van Den Brink W" first="Wim" last="Van Den Brink">Wim Van Den Brink</name><affiliation wicri:level="1"><nlm:aff id="A2">Amsterdam Institute for Addiction Research, Amsterdam, The Netherlands</nlm:aff><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Amsterdam Institute for Addiction Research, Amsterdam</wicri:regionArea></affiliation></author><author><name sortKey="Koeter, Maarten W J" sort="Koeter, Maarten W J" uniqKey="Koeter M" first="Maarten W. J." last="Koeter">Maarten W. J. Koeter</name><affiliation wicri:level="1"><nlm:aff id="A2">Amsterdam Institute for Addiction Research, Amsterdam, The Netherlands</nlm:aff><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Amsterdam Institute for Addiction Research, Amsterdam</wicri:regionArea></affiliation></author><author><name sortKey="Carpentier, Pieter Jan" sort="Carpentier, Pieter Jan" uniqKey="Carpentier P" first="Pieter-Jan" last="Carpentier">Pieter-Jan Carpentier</name><affiliation wicri:level="1"><nlm:aff id="A3">Reinier van Arkel groep, ‘s-Hertogenbosch, The Netherlands</nlm:aff><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Reinier van Arkel groep, ‘s-Hertogenbosch</wicri:regionArea></affiliation></author><author><name sortKey="Van Emmerik Van Oortmerssen, Katelijne" sort="Van Emmerik Van Oortmerssen, Katelijne" uniqKey="Van Emmerik Van Oortmerssen K" first="Katelijne" last="Van Emmerik-Van Oortmerssen">Katelijne Van Emmerik-Van Oortmerssen</name><affiliation wicri:level="1"><nlm:aff id="A2">Amsterdam Institute for Addiction Research, Amsterdam, The Netherlands</nlm:aff><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Amsterdam Institute for Addiction Research, Amsterdam</wicri:regionArea></affiliation><affiliation wicri:level="1"><nlm:aff id="A4">Arkin, Amsterdam, The Netherlands</nlm:aff><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Arkin, Amsterdam</wicri:regionArea></affiliation></author><author><name sortKey="Kaye, Sharlene" sort="Kaye, Sharlene" uniqKey="Kaye S" first="Sharlene" last="Kaye">Sharlene Kaye</name><affiliation wicri:level="1"><nlm:aff id="A5">National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia</nlm:aff><country xml:lang="fr">Australie</country><wicri:regionArea>National Drug and Alcohol Research Centre, University of New South Wales, Sydney</wicri:regionArea></affiliation></author><author><name sortKey="Skutle, Arvid" sort="Skutle, Arvid" uniqKey="Skutle A" first="Arvid" last="Skutle">Arvid Skutle</name><affiliation wicri:level="1"><nlm:aff id="A6">Bergen Clinics Foundation, Bergen, Norway</nlm:aff><country xml:lang="fr">Norvège</country><wicri:regionArea>Bergen Clinics Foundation, Bergen</wicri:regionArea></affiliation></author><author><name sortKey="Bu, Eli Torild H" sort="Bu, Eli Torild H" uniqKey="Bu E" first="Eli-Torild H." last="Bu">Eli-Torild H. Bu</name><affiliation wicri:level="1"><nlm:aff id="A6">Bergen Clinics Foundation, Bergen, Norway</nlm:aff><country xml:lang="fr">Norvège</country><wicri:regionArea>Bergen Clinics Foundation, Bergen</wicri:regionArea></affiliation></author><author><name sortKey="Franck, Johan" sort="Franck, Johan" uniqKey="Franck J" first="Johan" last="Franck">Johan Franck</name><affiliation wicri:level="1"><nlm:aff id="A7">Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden</nlm:aff><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Clinical Neuroscience, Karolinska Institutet, Stockholm</wicri:regionArea></affiliation></author><author><name sortKey="Konstenius, Maija" sort="Konstenius, Maija" uniqKey="Konstenius M" first="Maija" last="Konstenius">Maija Konstenius</name><affiliation wicri:level="1"><nlm:aff id="A7">Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden</nlm:aff><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Clinical Neuroscience, Karolinska Institutet, Stockholm</wicri:regionArea></affiliation></author><author><name sortKey="Moggi, Franz" sort="Moggi, Franz" uniqKey="Moggi F" first="Franz" last="Moggi">Franz Moggi</name><affiliation wicri:level="1"><nlm:aff id="A8">University Hospital of Psychiatry Berne, Department of Psychology, University of Fribourg, Switzerland</nlm:aff><country xml:lang="fr">Suisse</country><wicri:regionArea>University Hospital of Psychiatry Berne, Department of Psychology, University of Fribourg</wicri:regionArea></affiliation></author><author><name sortKey="Dom, Geert" sort="Dom, Geert" uniqKey="Dom G" first="Geert" last="Dom">Geert Dom</name><affiliation wicri:level="1"><nlm:aff id="A9">Collaborative Antwerp Psychiatry Research Institute (CAPRI, UA), Boechout, Belgium</nlm:aff><country xml:lang="fr">Belgique</country><wicri:regionArea>Collaborative Antwerp Psychiatry Research Institute (CAPRI, UA), Boechout</wicri:regionArea></affiliation></author><author><name sortKey="Verspreet, Sofie" sort="Verspreet, Sofie" uniqKey="Verspreet S" first="Sofie" last="Verspreet">Sofie Verspreet</name><affiliation wicri:level="1"><nlm:aff id="A9">Collaborative Antwerp Psychiatry Research Institute (CAPRI, UA), Boechout, Belgium</nlm:aff><country xml:lang="fr">Belgique</country><wicri:regionArea>Collaborative Antwerp Psychiatry Research Institute (CAPRI, UA), Boechout</wicri:regionArea></affiliation></author><author><name sortKey="Demetrovics, Zsolt" sort="Demetrovics, Zsolt" uniqKey="Demetrovics Z" first="Zsolt" last="Demetrovics">Zsolt Demetrovics</name><affiliation wicri:level="1"><nlm:aff id="A10">Institute of Psychology, Eötvös Loránd University, Budapest, Hungary</nlm:aff><country xml:lang="fr">Hongrie</country><wicri:regionArea>Institute of Psychology, Eötvös Loránd University, Budapest</wicri:regionArea></affiliation></author><author><name sortKey="Kapitany Foveny, Mate" sort="Kapitany Foveny, Mate" uniqKey="Kapitany Foveny M" first="Máté" last="Kapitány-Fövény">Máté Kapitány-Fövény</name><affiliation wicri:level="1"><nlm:aff id="A10">Institute of Psychology, Eötvös Loránd University, Budapest, Hungary</nlm:aff><country xml:lang="fr">Hongrie</country><wicri:regionArea>Institute of Psychology, Eötvös Loránd University, Budapest</wicri:regionArea></affiliation><affiliation wicri:level="1"><nlm:aff id="A21">Nyírő Gyula Hospital Drug Outpatient and Prevention Center, Budapest, Hungary</nlm:aff><country xml:lang="fr">Hongrie</country><wicri:regionArea>Nyírő Gyula Hospital Drug Outpatient and Prevention Center, Budapest</wicri:regionArea></affiliation></author><author><name sortKey="Fatseas, Melina" sort="Fatseas, Melina" uniqKey="Fatseas M" first="Melina" last="Fatséas">Melina Fatséas</name><affiliation wicri:level="1"><nlm:aff id="A11">Laboratoire de psychiatrie Département d’addictologie, Université de Bordeaux, France</nlm:aff><country xml:lang="fr">France</country><wicri:regionArea>Laboratoire de psychiatrie Département d’addictologie, Université de Bordeaux</wicri:regionArea></affiliation></author><author><name sortKey="Auriacombe, Marc" sort="Auriacombe, Marc" uniqKey="Auriacombe M" first="Marc" last="Auriacombe">Marc Auriacombe</name><affiliation wicri:level="1"><nlm:aff id="A11">Laboratoire de psychiatrie Département d’addictologie, Université de Bordeaux, France</nlm:aff><country xml:lang="fr">France</country><wicri:regionArea>Laboratoire de psychiatrie Département d’addictologie, Université de Bordeaux</wicri:regionArea></affiliation></author><author><name sortKey="Schillinger, Arild" sort="Schillinger, Arild" uniqKey="Schillinger A" first="Arild" last="Schillinger">Arild Schillinger</name><affiliation wicri:level="1"><nlm:aff id="A12">Østfoldklinikken, Fredrikstad, Norway</nlm:aff><country xml:lang="fr">Norvège</country><wicri:regionArea>Østfoldklinikken, Fredrikstad</wicri:regionArea></affiliation></author><author><name sortKey="Seitz, Andrea" sort="Seitz, Andrea" uniqKey="Seitz A" first="Andrea" last="Seitz">Andrea Seitz</name><affiliation wicri:level="1"><nlm:aff id="A13">University Hospital of Psychiatry Berne, Switzerland</nlm:aff><country xml:lang="fr">Suisse</country><wicri:regionArea>University Hospital of Psychiatry Berne</wicri:regionArea></affiliation></author><author><name sortKey="Johnson, Brian" sort="Johnson, Brian" uniqKey="Johnson B" first="Brian" last="Johnson">Brian Johnson</name><affiliation wicri:level="1"><nlm:aff id="A14">Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY</wicri:regionArea></affiliation><affiliation wicri:level="1"><nlm:aff id="A15">Department of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY</wicri:regionArea></affiliation></author><author><name sortKey="Faraone, Stephen V" sort="Faraone, Stephen V" uniqKey="Faraone S" first="Stephen V." last="Faraone">Stephen V. Faraone</name><affiliation wicri:level="1"><nlm:aff id="A14">Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY</wicri:regionArea></affiliation><affiliation wicri:level="1"><nlm:aff id="A15">Department of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY</wicri:regionArea></affiliation></author><author><name sortKey="Ramos Quiroga, J Antoni" sort="Ramos Quiroga, J Antoni" uniqKey="Ramos Quiroga J" first="J. Antoni" last="Ramos-Quiroga">J. Antoni Ramos-Quiroga</name><affiliation wicri:level="1"><nlm:aff id="A16">Servei de Psiquiatria, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Spain</nlm:aff><country xml:lang="fr">Espagne</country><wicri:regionArea>Servei de Psiquiatria, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona</wicri:regionArea></affiliation></author><author><name sortKey="Casas, Miguel" sort="Casas, Miguel" uniqKey="Casas M" first="Miguel" last="Casas">Miguel Casas</name><affiliation wicri:level="1"><nlm:aff id="A16">Servei de Psiquiatria, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Spain</nlm:aff><country xml:lang="fr">Espagne</country><wicri:regionArea>Servei de Psiquiatria, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona</wicri:regionArea></affiliation></author><author><name sortKey="Allsop, Steve" sort="Allsop, Steve" uniqKey="Allsop S" first="Steve" last="Allsop">Steve Allsop</name><affiliation wicri:level="1"><nlm:aff id="A17">National Drug Research Institute/Curtin University of Technology, Perth, Australia</nlm:aff><country xml:lang="fr">Australie</country><wicri:regionArea>National Drug Research Institute/Curtin University of Technology, Perth</wicri:regionArea></affiliation></author><author><name sortKey="Carruthers, Susan" sort="Carruthers, Susan" uniqKey="Carruthers S" first="Susan" last="Carruthers">Susan Carruthers</name><affiliation wicri:level="1"><nlm:aff id="A17">National Drug Research Institute/Curtin University of Technology, Perth, Australia</nlm:aff><country xml:lang="fr">Australie</country><wicri:regionArea>National Drug Research Institute/Curtin University of Technology, Perth</wicri:regionArea></affiliation></author><author><name sortKey="Barta, Csaba" sort="Barta, Csaba" uniqKey="Barta C" first="Csaba" last="Barta">Csaba Barta</name><affiliation wicri:level="1"><nlm:aff id="A18">Institute of Medical Chemistry, Molecular Biology, Pathobiochemistry, Semmelweis University, Budapest, Hungary</nlm:aff><country xml:lang="fr">Hongrie</country><wicri:regionArea>Institute of Medical Chemistry, Molecular Biology, Pathobiochemistry, Semmelweis University, Budapest</wicri:regionArea></affiliation></author><author><name sortKey="Schoevers, Robert A" sort="Schoevers, Robert A" uniqKey="Schoevers R" first="Robert A." last="Schoevers">Robert A. Schoevers</name><affiliation wicri:level="1"><nlm:aff id="A19">Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands</nlm:aff><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen</wicri:regionArea></affiliation></author><author><name sortKey="Levin, Frances R" sort="Levin, Frances R" uniqKey="Levin F" first="Frances R." last="Levin">Frances R. Levin</name><affiliation wicri:level="1"><nlm:aff id="A20">Columbia University/The New York State Psychiatric Institute, New York, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Columbia University/The New York State Psychiatric Institute, New York</wicri:regionArea></affiliation></author></analytic><series><title level="j">Drug and alcohol dependence</title><idno type="ISSN">0376-8716</idno><idno type="eISSN">1879-0046</idno><imprint><date when="2013">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec id="S1"><title>Background</title><p id="P2">To detect attention deficit hyperactivity disorder (ADHD) in treatment seeking substance use disorders (SUD) patients, a valid screening instrument is needed.</p></sec><sec id="S2"><title>Objectives</title><p id="P3">To test the performance of the Adult ADHD Self-Report Scale V1.1(ASRS) for adult ADHD in an international sample of treatment seeking SUD patients for DSM-IV-TR; for the proposed DSM-5 criteria; in different subpopulations, at intake and 1–2 weeks after intake; using different scoring algorithms; and different externalizing disorders as external criterion (including adult ADHD, bipolar disorder, antisocial and borderline personality disorder).</p></sec><sec id="S3"><title>Methods</title><p id="P4">In 1138 treatment seeking SUD subjects, ASRS performance was determined using diagnoses based on Conner’s Adult ADHD Diagnostic Interview for DSM-IV (CAADID) as gold standard.</p></sec><sec id="S4"><title>Results</title><p id="P5">The prevalence of adult ADHD was 13.0% (95% CI: 11.0–15.0%). The overall positive predictive value (PPV) of the ASRS was 0.26 (95% CI: 0.22–0.30), the negative predictive value (NPV) was 0.97 (95% CI: 0.96–0.98). The sensitivity (0.84, 95% CI: 0.76–0.88) and specificity (0.66, 95% CI: 0.63–0.69) measured at admission were similar to the sensitivity (0.88,95% CI: 0.83–0.93) and specificity (0.67,95% CI: 0.64–0.70) measured 2 weeks after admission. Sensitivity was similar, but specificity was significantly better in patients with alcohol compared to (illicit) drugs as the primary substance of abuse (0.76 vs. 0.56). ASRS was not a good screener for externalizing disorders other than ADHD.</p></sec><sec id="S5"><title>Conclusions</title><p id="P6">The ASRS is a sensitive screener for identifying possible ADHD cases with very few missed cases among those screening negative in this population.</p></sec></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-journal-id">7513587</journal-id><journal-id journal-id-type="pubmed-jr-id">3445</journal-id><journal-id journal-id-type="nlm-ta">Drug Alcohol Depend</journal-id><journal-id journal-id-type="iso-abbrev">Drug Alcohol Depend</journal-id><journal-title-group><journal-title>Drug and alcohol dependence</journal-title></journal-title-group><issn pub-type="ppub">0376-8716</issn><issn pub-type="epub">1879-0046</issn></journal-meta><article-meta><article-id pub-id-type="pmid">23660242</article-id><article-id pub-id-type="pmc">4083506</article-id><article-id pub-id-type="doi">10.1016/j.drugalcdep.2013.04.010</article-id><article-id pub-id-type="manuscript">NIHMS598068</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>van de Glind</surname><given-names>Geurt</given-names></name><xref ref-type="aff" rid="A1">a</xref><xref ref-type="aff" rid="A2">b</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>van den Brink</surname><given-names>Wim</given-names></name><xref ref-type="aff" rid="A2">b</xref></contrib><contrib contrib-type="author"><name><surname>Koeter</surname><given-names>Maarten W.J.</given-names></name><xref ref-type="aff" rid="A2">b</xref></contrib><contrib contrib-type="author"><name><surname>Carpentier</surname><given-names>Pieter-Jan</given-names></name><xref ref-type="aff" rid="A3">c</xref></contrib><contrib contrib-type="author"><name><surname>van Emmerik-van Oortmerssen</surname><given-names>Katelijne</given-names></name><xref ref-type="aff" rid="A2">b</xref><xref ref-type="aff" rid="A4">d</xref></contrib><contrib contrib-type="author"><name><surname>Kaye</surname><given-names>Sharlene</given-names></name><xref ref-type="aff" rid="A5">e</xref></contrib><contrib contrib-type="author"><name><surname>Skutle</surname><given-names>Arvid</given-names></name><xref ref-type="aff" rid="A6">f</xref></contrib><contrib contrib-type="author"><name><surname>Bu</surname><given-names>Eli-Torild H.</given-names></name><xref ref-type="aff" rid="A6">f</xref></contrib><contrib contrib-type="author"><name><surname>Franck</surname><given-names>Johan</given-names></name><xref ref-type="aff" rid="A7">g</xref></contrib><contrib contrib-type="author"><name><surname>Konstenius</surname><given-names>Maija</given-names></name><xref ref-type="aff" rid="A7">g</xref></contrib><contrib contrib-type="author"><name><surname>Moggi</surname><given-names>Franz</given-names></name><xref ref-type="aff" rid="A8">h</xref></contrib><contrib contrib-type="author"><name><surname>Dom</surname><given-names>Geert</given-names></name><xref ref-type="aff" rid="A9">i</xref></contrib><contrib contrib-type="author"><name><surname>Verspreet</surname><given-names>Sofie</given-names></name><xref ref-type="aff" rid="A9">i</xref></contrib><contrib contrib-type="author"><name><surname>Demetrovics</surname><given-names>Zsolt</given-names></name><xref ref-type="aff" rid="A10">j</xref></contrib><contrib contrib-type="author"><name><surname>Kapitány-Fövény</surname><given-names>Máté</given-names></name><xref ref-type="aff" rid="A10">j</xref><xref ref-type="aff" rid="A21">u</xref></contrib><contrib contrib-type="author"><name><surname>Fatséas</surname><given-names>Melina</given-names></name><xref ref-type="aff" rid="A11">k</xref></contrib><contrib contrib-type="author"><name><surname>Auriacombe</surname><given-names>Marc</given-names></name><xref ref-type="aff" rid="A11">k</xref></contrib><contrib contrib-type="author"><name><surname>Schillinger</surname><given-names>Arild</given-names></name><xref ref-type="aff" rid="A12">l</xref></contrib><contrib contrib-type="author"><name><surname>Seitz</surname><given-names>Andrea</given-names></name><xref ref-type="aff" rid="A13">m</xref></contrib><contrib contrib-type="author"><name><surname>Johnson</surname><given-names>Brian</given-names></name><xref ref-type="aff" rid="A14">n</xref><xref ref-type="aff" rid="A15">o</xref></contrib><contrib contrib-type="author"><name><surname>Faraone</surname><given-names>Stephen V.</given-names></name><xref ref-type="aff" rid="A14">n</xref><xref ref-type="aff" rid="A15">o</xref></contrib><contrib contrib-type="author"><name><surname>Ramos-Quiroga</surname><given-names>J. Antoni</given-names></name><xref ref-type="aff" rid="A16">p</xref></contrib><contrib contrib-type="author"><name><surname>Casas</surname><given-names>Miguel</given-names></name><xref ref-type="aff" rid="A16">p</xref></contrib><contrib contrib-type="author"><name><surname>Allsop</surname><given-names>Steve</given-names></name><xref ref-type="aff" rid="A17">q</xref></contrib><contrib contrib-type="author"><name><surname>Carruthers</surname><given-names>Susan</given-names></name><xref ref-type="aff" rid="A17">q</xref></contrib><contrib contrib-type="author"><name><surname>Barta</surname><given-names>Csaba</given-names></name><xref ref-type="aff" rid="A18">r</xref></contrib><contrib contrib-type="author"><name><surname>Schoevers</surname><given-names>Robert A.</given-names></name><xref ref-type="aff" rid="A19">s</xref></contrib><contrib contrib-type="author"><name><surname>Levin</surname><given-names>Frances R.</given-names></name><xref ref-type="aff" rid="A20">t</xref></contrib><contrib contrib-type="author"><collab>IASP Research Group</collab><xref ref-type="author-notes" rid="FN1">1</xref></contrib></contrib-group><aff id="A1"><label>a</label>Trimbos-instituut and ICASA Foundation, Utrecht, The Netherlands</aff><aff id="A2"><label>b</label>Amsterdam Institute for Addiction Research, Amsterdam, The Netherlands</aff><aff id="A3"><label>c</label>Reinier van Arkel groep, ‘s-Hertogenbosch, The Netherlands</aff><aff id="A4"><label>d</label>Arkin, Amsterdam, The Netherlands</aff><aff id="A5"><label>e</label>National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia</aff><aff id="A6"><label>f</label>Bergen Clinics Foundation, Bergen, Norway</aff><aff id="A7"><label>g</label>Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden</aff><aff id="A8"><label>h</label>University Hospital of Psychiatry Berne, Department of Psychology, University of Fribourg, Switzerland</aff><aff id="A9"><label>i</label>Collaborative Antwerp Psychiatry Research Institute (CAPRI, UA), Boechout, Belgium</aff><aff id="A10"><label>j</label>Institute of Psychology, Eötvös Loránd University, Budapest, Hungary</aff><aff id="A11"><label>k</label>Laboratoire de psychiatrie Département d’addictologie, Université de Bordeaux, France</aff><aff id="A12"><label>l</label>Østfoldklinikken, Fredrikstad, Norway</aff><aff id="A13"><label>m</label>University Hospital of Psychiatry Berne, Switzerland</aff><aff id="A14"><label>n</label>Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY, USA</aff><aff id="A15"><label>o</label>Department of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA</aff><aff id="A16"><label>p</label>Servei de Psiquiatria, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Spain</aff><aff id="A17"><label>q</label>National Drug Research Institute/Curtin University of Technology, Perth, Australia</aff><aff id="A18"><label>r</label>Institute of Medical Chemistry, Molecular Biology, Pathobiochemistry, Semmelweis University, Budapest, Hungary</aff><aff id="A19"><label>s</label>Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands</aff><aff id="A20"><label>t</label>Columbia University/The New York State Psychiatric Institute, New York, USA</aff><aff id="A21"><label>u</label>Nyírő Gyula Hospital Drug Outpatient and Prevention Center, Budapest, Hungary</aff><author-notes><corresp id="cor1"><label>*</label>Corresponding author at: ICASA Foundation, DaCostakade 45, P.O. Box 725,3500 AS Utrecht, The Netherlands. Tel.: +31 302971101; fax: +31 302971111. <email>gglind@trimbos.nl</email> (G. van de Glind)</corresp><fn id="FN1"><label>1</label><p id="P1">See <xref ref-type="app" rid="APP1">Appendix A</xref> for the persons participated in this study.</p></fn></author-notes><pub-date pub-type="nihms-submitted"><day>5</day><month>6</month><year>2014</year></pub-date><pub-date pub-type="epub"><day>06</day><month>5</month><year>2013</year></pub-date><pub-date pub-type="ppub"><day>1</day><month>10</month><year>2013</year></pub-date><pub-date pub-type="pmc-release"><day>07</day><month>7</month><year>2014</year></pub-date><volume>132</volume><issue>3</issue><fpage>587</fpage><lpage>596</lpage><pmc-comment>elocation-id from pubmed: 10.1016/j.drugalcdep.2013.04.010</pmc-comment>
<permissions><copyright-statement>© 2013 Elsevier Ireland Ltd. All rights reserved.</copyright-statement><copyright-year>2013</copyright-year></permissions><abstract><sec id="S1"><title>Background</title><p id="P2">To detect attention deficit hyperactivity disorder (ADHD) in treatment seeking substance use disorders (SUD) patients, a valid screening instrument is needed.</p></sec><sec id="S2"><title>Objectives</title><p id="P3">To test the performance of the Adult ADHD Self-Report Scale V1.1(ASRS) for adult ADHD in an international sample of treatment seeking SUD patients for DSM-IV-TR; for the proposed DSM-5 criteria; in different subpopulations, at intake and 1–2 weeks after intake; using different scoring algorithms; and different externalizing disorders as external criterion (including adult ADHD, bipolar disorder, antisocial and borderline personality disorder).</p></sec><sec id="S3"><title>Methods</title><p id="P4">In 1138 treatment seeking SUD subjects, ASRS performance was determined using diagnoses based on Conner’s Adult ADHD Diagnostic Interview for DSM-IV (CAADID) as gold standard.</p></sec><sec id="S4"><title>Results</title><p id="P5">The prevalence of adult ADHD was 13.0% (95% CI: 11.0–15.0%). The overall positive predictive value (PPV) of the ASRS was 0.26 (95% CI: 0.22–0.30), the negative predictive value (NPV) was 0.97 (95% CI: 0.96–0.98). The sensitivity (0.84, 95% CI: 0.76–0.88) and specificity (0.66, 95% CI: 0.63–0.69) measured at admission were similar to the sensitivity (0.88,95% CI: 0.83–0.93) and specificity (0.67,95% CI: 0.64–0.70) measured 2 weeks after admission. Sensitivity was similar, but specificity was significantly better in patients with alcohol compared to (illicit) drugs as the primary substance of abuse (0.76 vs. 0.56). ASRS was not a good screener for externalizing disorders other than ADHD.</p></sec><sec id="S5"><title>Conclusions</title><p id="P6">The ASRS is a sensitive screener for identifying possible ADHD cases with very few missed cases among those screening negative in this population.</p></sec></abstract><kwd-group><kwd>ADHD</kwd><kwd>Substance use disorders</kwd><kwd>Prevalence</kwd><kwd>Attention/deficit hyperactivity disorder</kwd><kwd>Validity</kwd><kwd>ASRS</kwd><kwd>Addiction</kwd><kwd>Psychiatry</kwd></kwd-group></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Pmc/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E10 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd -nk 001E10 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Pmc
|étape= Curation
|type= RBID
|clé= PMC:4083506
|texte= Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/RBID.i -Sk "pubmed:23660242" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |